A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan ( XELOXIRI ) in patients with locally advanced rectal cancer

Author:

Matsuda Chu12ORCID,Kudo Toshihiro13,Morimoto Yoshihiro1ORCID,Kagawa Yoshinori45,Tei Mitsuyoshi6ORCID,Ide Yoshihito78,Miyoshi Norikatsu1ORCID,Takahashi Hidekazu1,Uemura Mamoru1,Takemasa Ichiro9ORCID,Satoh Taroh1,Mizushima Tsunekazu110ORCID,Murata Kohei4,Doki Yuichiro1,Eguchi Hidetoshi1ORCID,

Affiliation:

1. Department of Gastroenterological Surgery, Graduate School of Medicine Osaka University Osaka Japan

2. Department of Surgery, Osaka International Cancer Institute Osaka Prefectural Hospital Organization Osaka Japan

3. Department of Medical Oncology, Osaka International Cancer Institute Osaka Prefectural Hospital Organization Osaka Japan

4. Department of Gastroenterological Surgery Kansai Rosai Hospital Amagasaki Japan

5. Department of Gastroenterological Surgery Osaka General Medical Center Osaka Japan

6. Department of Surgery Osaka Rosai Hospital Osaka Japan

7. Department of Surgery Yao Municipal Hospital Osaka Japan

8. Department of Surgery Japan Community Health care Organization (JCHO) Osaka Hospital Osaka Japan

9. Department of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan

10. Department of Therapeutics for Inflammatory Bowel Diseases, Graduate School of Medicine Osaka University Osaka Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3